Trial intelligence / Profile preview

Memantine vs sodium valproate for migraine prophylaxis

IRCT20180624040229N1Phase 3Completed

Sponsor
Ardabil University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of memantine and valproic acid in migraine (2 arms), sponsored by Ardabil University of Medical Sciences. Started Jan 2018; status: completed.

02

Drugs

memantinevalproic acid
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20180624040229N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180624040229N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call